Title : Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse.

Pub. Date : 2016 Oct

PMID : 26742940






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse. folfirinox solute carrier family 29 member 1 (Augustine blood group) Homo sapiens
2 RESULTS: The survival analysis, carried out on 70 patients regardless of hENT1 expression, showed a statistically longer OS and PFS in the group treated with FOLFIRINOX compared to GEM. folfirinox solute carrier family 29 member 1 (Augustine blood group) Homo sapiens